Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Cancer Causes Control. 2020 Apr 13;31(6):549–557. doi: 10.1007/s10552-020-01298-w

Table 3.

Association between recent alcohol consumption and risk of MDS by subtype

RA/RN/RT/RARS RCMD RAEB-1/RAEB-2 MDS del(5q) t-MDS
Cases, n(%) Adjusted OR (95% CI)a Cases, n(%) Adjusted OR (95% CI)a Cases, n(%) Adjusted OR (95% CI)a Cases, n(%) Adjusted OR (95% CI)a Cases, n(%) Adjusted OR (95% CI)a
n (%) 72 (18) 106 (27) 128 (32) 27 (7) 40 (10)
Lifetime Alcohol consumption
Abstainer 8 (22) 0.70 (0.28, 1.75) 16 (15) 1.14 (0.55, 2.34) 17 (13) 1.01 (0.53, 1.95) 4 (15) 1.08 (0.32, 3.72) 4 (10) 0.60 (0.16, 2.30)
Occasional 19 (26) Ref 26 (25) Ref 37 (29) Ref 12 (44) Ref 12 (30) Ref
Light 25 (35) 0.87 (0.44, 1.73) 39 (37) 0.73 (0.41, 1.30) 46 (36) 0.67 (0.40, 1.12) 6 (22) 0.39 (0.13, 1.19) 14 (35) 0.64 (0.25, 1.64)
Moderate/Heavy 19 (26) 1.13 (0.53, 2.40) 25 (24) 0.87 (0.46, 1.64) 28 (22) 0.68 (0.38, 1.22) 5 (19) 0.45 (0.14, 1.45) 9 (22) 0.80 (0.28, 2.29)

Abbreviations: Confidence interval (CI); Myelodysplastic syndromes (MDS); MDS with deletion of 5q (MDS del(5q)); Odds ratio (OR); Reference (Ref); Refractory anemia (RA); Refractory anemia with excess blasts, types 1 (RAEB-1) and 2 (RAEB-2); Refractory anemia with ring sideroblasts (RARS); Refractory cytopenia with multilineage dysplasia (RCMD); Refractory neutropenia (RN); Refractory thrombocytopenia (RT); therapy-related MDS (t-MDS)

Columns may not sum to totals due to missing data for 2 cases, 2 controls, and excluded subgroups; MDS unclassifiable (n=21) and not-otherwise-specified (n=4) excluded from analyses; Matching variables included age-decile and sex;

a

Adjusted for benzene exposure, BMI group, household income, radiation exposure, smoking status, age (continuous), and sex